The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Black Diamond Therapeutics Inc shares valued at $11,997,749 were sold by BIOTECH GROWTH N V on Mar 19 ’25. At $2.07 per share, BIOTECH GROWTH N V sold 5,784,292 shares. The insider’s holdings dropped to 2,733,547 shares worth approximately $4.32 million following the completion of this transaction.
Also, Versant Venture Capital VI, L. sold 221,600 shares, netting a total of over 1,400,556 in proceeds. Following the sale of shares at $6.32 each, the insider now holds 3,726,341 shares.
Before that, David Epstein had added 50,000 shares to its account. In a trade valued at $310,000, the Former Employer bought Black Diamond Therapeutics Inc shares for $6.20 each.
As published in their initiating research note from Raymond James on July 31, 2024, Black Diamond Therapeutics Inc [BDTX] has been an Outperform and the price target has been revised to $20. Analysts at Piper Sandler started covering the stock with ‘”an Overweight”‘ outlook in a report released in mid July. As of June 30, 2023, Stifel has increased its “Hold” rating to a “Buy” for BDTX. Earlier on June 28, 2023, H.C. Wainwright upgraded its rating. Their new recommendation was “a Buy” for BDTX stock which previously was a “a Neutral”.
Analyzing BDTX Stock Performance
During the last five days, there has been a drop of approximately -0.63%. Over the course of the year, Black Diamond Therapeutics Inc shares have dropped approximately -26.17%. Shares of the company reached a 52-week high of $2.8200 on 01/31/25 and a 52-week low of $1.4300 on 04/02/25. A 50-day SMA is recorded $2.0600, while a 200-day SMA reached $3.5534.
Support And Resistance Levels for Black Diamond Therapeutics Inc (BDTX)
According to the 24-hour chart, there is a support level at 1.4767, which, if violated, would cause prices to drop to 1.3733. In the upper region, resistance lies at 1.6367. The next price resistance is at 1.6933. RSI (Relative Strength Index) is 39.89 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.1279, which suggests the price will decrease in the coming days. Percent R is at 88.89%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
